J‑Receptor–Mediated Respiratory Reflexes and Clinical Implications

Pathophysiology and Reflex Responses

Pulmonary embolism activates J receptors because the embolus produces pulmonary vascular congestion and elevates pulmonary artery pressure, leading to rapid shallow breathing and dyspnea. 1
The hallmark reflex of J‑receptor stimulation is rapid, shallow breathing (tachypnea with reduced tidal volume), which directly contributes to the sensation of dyspnea in pulmonary congestion. This pattern arises from increased respiratory frequency driven by mechanical stimulation of the receptors. 1
Resolution of the embolic obstruction lowers pulmonary artery pressure, and the associated tachypnea improves accordingly. 1

Therapeutic reduction of pulmonary capillary pressure (e.g., diuretics, vasodilators, afterload reduction) is recommended to lower left‑atrial pressure and thereby diminish J‑receptor stimulation. This approach addresses the underlying hemodynamic cause rather than the receptors themselves. 2

Untreated pulmonary embolism carries a 25–30 % mortality rate, whereas adequate anticoagulation reduces mortality to < 8 %. Anticoagulation therefore is essential to prevent fatal outcomes. [2][3]
In massive pulmonary embolism, thrombolytic therapy or surgical embolectomy is advised to rapidly decrease pulmonary vascular resistance and right‑ventricular afterload, mitigating the hemodynamic trigger of J‑receptor activation. [2][3]
Supportive care for hypoxemia in pulmonary embolism focuses on correcting ventilation‑perfusion mismatch, shunting, reduced mixed‑venous oxygen saturation, and impaired diffusion, all of which exacerbate respiratory distress. 3

When ventilating patients with left‑ventricular dysfunction, clinicians should avoid excessive positive end‑expiratory pressure (PEEP) because high PEEP can raise pulmonary capillary pressure and further stimulate J receptors. 2

J receptors do not initiate cough; cough reflexes are mediated by specialized cough receptors and airway C‑fibers. This distinction helps avoid misattributing cough to J‑receptor activity. [4][5]
J receptors are physiologically distinct from rapidly adapting receptors (RARs) and slowly adapting receptors (SARs), which primarily respond to lung inflation and deflation. Recognizing these differences is important for interpreting respiratory reflex patterns. [6][7]

J receptors are unmyelinated vagal afferent nerve endings with slow conduction velocities located in the interstitial tissues immediately adjacent to pulmonary capillaries 8
J receptors are quiescent during normal tidal breathing and relatively unresponsive to lung inflation, unlike rapidly adapting receptors and slowly adapting receptors 9, 10

The American Thoracic Society notes that J receptors are activated by increased pulmonary capillary pressure leading to elevated interstitial pressure or volume, as seen in conditions such as heart failure and pulmonary edema 11
J receptors have a low activation threshold and can be stimulated by small increases in pulmonary capillary pressure, resulting in rapid shallow breathing 11

The American College of Chest Physicians states that J receptor activation produces rapid shallow breathing as the primary respiratory reflex response, contributing to the sensation of dyspnea in pulmonary congestion 11
J receptors are listed among the afferent sources for respiratory sensation, specifically responding to pulmonary vascular congestion as their adequate stimulus, according to the American Journal of Respiratory and Critical Care Medicine 11

J receptors do not respond to capsaicin through direct receptor activation, but rather through secondary effects, as noted by the American College of Chest Physicians 9, 10
J receptors are not involved in cough initiation, which is primarily the role of C-fiber cough receptors and specialized cough receptors in the airways, as stated by the American College of Chest Physicians 12, 13

The American Heart Association notes that there is no direct clinical management of J receptors themselves, but rather treatment targets the underlying conditions that activate them, such as heart failure and pulmonary edema 11
Understanding J receptor physiology explains why patients with pulmonary vascular congestion experience dyspnea even before overt pulmonary edema develops, as explained by the American Journal of Respiratory and Critical Care Medicine 11